Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Develop a Prognostic Model for Predicting Survival and Treatment Response for Advanced Gastric Cancer Patients After Neoadjuvant Therapy by Analyzing Hematological Markers Dynamic Load

NCT06573307 is registered in ClinicalTrials.gov with Chang-Ming Huang, Prof. as lead sponsor.

NCT NCT06573307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06573307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Develop a Prognostic Model for Predicting Survival and Treatment Response for Advanced Gastric Cancer Patients After Neoadjuvant Therapy by Analyzing Hematological Markers Dynamic Load
Lead sponsor
Chang-Ming Huang, Prof.
Phase
Observational
Overall status
Completed
Start date
June 10, 2024
Completion date
August 26, 2024
Enrollment
442 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer